You are here: All Products  > Chi-Med Starts First US Trial of Fruquintinib, an Anti-Angiogenesis Drug

Chi-Med Starts First US Trial of Fruquintinib, an Anti-Angiogenesis Drug

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products